Subclinical Vascular Brain Lesions in Young Adults With Acute Ischemic Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 4 11 2021
medline: 26 4 2022
entrez: 3 11 2021
Statut: ppublish

Résumé

Subclinical vascular brain lesions are highly prevalent in elderly patients with stroke. Little is known about predisposing factors and their impact on long-term outcome of patients with stroke at a young age. We quantified magnetic resonance-defined subclinical vascular brain lesions, including lacunes and white matter hyperintensities, perivascular spaces and cerebral microbleeds, and assessed total small-vessel disease (SVD) score in patients with first-ever acute ischemic stroke aged 18 to 45 years, and followed them up, as part of the multicentre Italian Project on Stroke in Young Adults. The primary end point was a composite of ischemic stroke, transient ischemic attack, myocardial infarction, or other arterial events. We assessed the predictive accuracy of magnetic resonance features and whether the addition of these markers improves outcome prediction over a validated clinical tool, such as the Italian Project on Stroke in Young Adults score. Among 591 patients (males, 53.8%; mean age, 37.5±6.4 years), 117 (19.8%) had subclinical vascular brain lesions. Family history of stroke was associated with lacunes (odds ratio, 2.24 [95% CI, 1.30-3.84]) and total SVD score (odds ratio, 2.06 [95% CI, 1.20-3.53] for score≥1), hypertension with white matter hyperintensities (odds ratio, 2.29 [95% CI, 1.22-4.32]). After a median follow-up of 36.0 months (25th-75th percentile, 38.0), lacunes and total SVD score were associated with primary end point (hazard ratio, 2.13 [95% CI, 1.17-3.90] for lacunes; hazard ratio, 2.17 [95% CI, 1.20-3.90] for total SVD score ≥1), and the secondary end point brain ischemia (hazard ratio, 2.55 [95% CI, 1.36-4.75] for lacunes; hazard ratio, 2.61 [95% CI, 1.42-4.80] for total SVD score ≥1). The predictive performances of the models, including magnetic resonance features were comparable to those of the random model. Adding individual magnetic resonance features to the Italian Project on Stroke in Young Adults score did not improve model prediction. Subclinical vascular brain lesions affect ≈2 in 10 young adults with ischemic stroke. Although lacunes and total SVD score are associated with thrombotic recurrence, they do not improve accuracy of outcome prediction over validated clinical predictors.

Sections du résumé

BACKGROUND
Subclinical vascular brain lesions are highly prevalent in elderly patients with stroke. Little is known about predisposing factors and their impact on long-term outcome of patients with stroke at a young age.
METHODS
We quantified magnetic resonance-defined subclinical vascular brain lesions, including lacunes and white matter hyperintensities, perivascular spaces and cerebral microbleeds, and assessed total small-vessel disease (SVD) score in patients with first-ever acute ischemic stroke aged 18 to 45 years, and followed them up, as part of the multicentre Italian Project on Stroke in Young Adults. The primary end point was a composite of ischemic stroke, transient ischemic attack, myocardial infarction, or other arterial events. We assessed the predictive accuracy of magnetic resonance features and whether the addition of these markers improves outcome prediction over a validated clinical tool, such as the Italian Project on Stroke in Young Adults score.
RESULTS
Among 591 patients (males, 53.8%; mean age, 37.5±6.4 years), 117 (19.8%) had subclinical vascular brain lesions. Family history of stroke was associated with lacunes (odds ratio, 2.24 [95% CI, 1.30-3.84]) and total SVD score (odds ratio, 2.06 [95% CI, 1.20-3.53] for score≥1), hypertension with white matter hyperintensities (odds ratio, 2.29 [95% CI, 1.22-4.32]). After a median follow-up of 36.0 months (25th-75th percentile, 38.0), lacunes and total SVD score were associated with primary end point (hazard ratio, 2.13 [95% CI, 1.17-3.90] for lacunes; hazard ratio, 2.17 [95% CI, 1.20-3.90] for total SVD score ≥1), and the secondary end point brain ischemia (hazard ratio, 2.55 [95% CI, 1.36-4.75] for lacunes; hazard ratio, 2.61 [95% CI, 1.42-4.80] for total SVD score ≥1). The predictive performances of the models, including magnetic resonance features were comparable to those of the random model. Adding individual magnetic resonance features to the Italian Project on Stroke in Young Adults score did not improve model prediction.
CONCLUSIONS
Subclinical vascular brain lesions affect ≈2 in 10 young adults with ischemic stroke. Although lacunes and total SVD score are associated with thrombotic recurrence, they do not improve accuracy of outcome prediction over validated clinical predictors.

Identifiants

pubmed: 34727743
doi: 10.1161/STROKEAHA.121.036038
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1190-1198

Investigateurs

Nicola Gilberti (N)
Paola Ferrazzi (P)
Elena Banfi (E)
Luca Librè (L)
Elisabetta Traverso (E)
Erika Schirinzi (E)
Federico Carimati (F)
Manuel Cappellari (M)
Giampiero Locatelli (G)
Laura Demelas (L)
Davide Ferrario (D)
Alessandra Persico (A)
Giovanni Orlandi (G)
Manuela Napoli (M)
Claudio Moratti (C)
Mario Guidotti (M)

Auteurs

Valeria De Giuli (V)

U.O. Neurologia (V.D.G.), Istituti Ospitalieri, ASST Cremona, Italia.

Mario Grassi (M)

Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Unità di Statistica Medica e Genomica, Università di Pavia, Italia (M. Grassi).

Michele Besana (M)

U.O. Radiologia (M. Besana), Istituti Ospitalieri, ASST Cremona, Italia.

Marialuisa Zedde (M)

S.C. Neurologia, Stroke Unit (M.Z.), Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Italia.

Andrea Zini (A)

IRCCS Istituto di Scienze Neurologiche di Bologna, UOC Neurologia e Rete Stroke metropolitana, Ospedale Maggiore, Italia (A.Z.).

Corrado Lodigiani (C)

Centro Trombosi (C.L.), IRCCS Humanitas Research Hospital, Rozzano-Milano, Italia.

Simona Marcheselli (S)

Neurologia d'Urgenza e Stroke Unit (S.M.), IRCCS Humanitas Research Hospital, Rozzano-Milano, Italia.

Anna Cavallini (A)

Stroke Unit (A. Cavallini), IRCCS Fondazione Istituto "C. Mondino", Pavia, Italia.

Giuseppe Micieli (G)

Neurologia d'Urgenza (G.M.), IRCCS Fondazione Istituto "C. Mondino", Pavia, Italia.

Maurizia Rasura (M)

Stroke Unit, Azienda Ospedaliera Sant'Andrea, Università "La Sapienza", Roma, Italia (M.R., R. Patella, A.S.).

Maria Luisa DeLodovici (ML)

U.O. Neurologia, Ospedale di Circolo, Università dell'Insubria, Varese, Italia (M.L.D.).

Giampaolo Tomelleri (G)

U.O. Neurologia, Azienda Ospedaliera-Universitaria Borgo Trento, Verona, Italia (G.T.).

Nicoletta Checcarelli (N)

U.O.C. Neurologia, Ospedale Valduce, Como, Italia (N.C.).

Alberto Chiti (A)

Neurologia, Azienda Ospedaliera Universitaria Pisana, Pisa, Italia (A. Chiti).

Elisa Giorli (E)

U.O. Neurologia, Ospedale S. Andrea, La Spezia, Italia (E.G.).

Massimo Del Sette (M)

U.O. Neurologia, IRCCS Policlinico San Martino, Genova, Italia (M.D.S.).

Lucia Tancredi (L)

U.O. Neurologia, Ospedale San Paolo, ASST Santi Paolo e Carlo, Milano, Italia (L.T.).

Antonella Toriello (A)

U.O.C. Neurologia, A.O Universitaria "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italia (A.T.).

Massimiliano Braga (M)

U.O.C Neurologia, Stroke Unit, ASST Vimercate, Italia (M. Braga, S. Beretta).

Andrea Morotti (A)

U.O. Neurologia, ASST Spedali Civili di Brescia, Brescia, Italia (A.M.).

Debora Pezzini (D)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica (D.P., M.L., V.M., S. Bonacina, A. Padovani, A. Pezzini), Università degli Studi di Brescia, Italia.

Martina Locatelli (M)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica (D.P., M.L., V.M., S. Bonacina, A. Padovani, A. Pezzini), Università degli Studi di Brescia, Italia.

Valentina Mazzoleni (V)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica (D.P., M.L., V.M., S. Bonacina, A. Padovani, A. Pezzini), Università degli Studi di Brescia, Italia.

Sonia Bonacina (S)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica (D.P., M.L., V.M., S. Bonacina, A. Padovani, A. Pezzini), Università degli Studi di Brescia, Italia.

Massimo Gamba (M)

Stroke Unit, Neurologia Vascolare, ASST Spedali Civili di Brescia, Brescia, Italia (M. Gamba, M.M.).

Mauro Magoni (M)

Stroke Unit, Neurologia Vascolare, ASST Spedali Civili di Brescia, Brescia, Italia (M. Gamba, M.M.).

Rosalba Patella (R)

Stroke Unit, Azienda Ospedaliera Sant'Andrea, Università "La Sapienza", Roma, Italia (M.R., R. Patella, A.S.).

Alessandra Spalloni (A)

Stroke Unit, Azienda Ospedaliera Sant'Andrea, Università "La Sapienza", Roma, Italia (M.R., R. Patella, A.S.).

Rosario Pascarella (R)

Neuroradiologia (R. Pascarella), Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, Italia.

Sandro Beretta (S)

U.O.C Neurologia, Stroke Unit, ASST Vimercate, Italia (M. Braga, S. Beretta).

Alessandro Padovani (A)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica (D.P., M.L., V.M., S. Bonacina, A. Padovani, A. Pezzini), Università degli Studi di Brescia, Italia.

Roberto Gasparotti (R)

U.O. Neuroradiologia, Dipartimento di Scienze Mediche e Chirurgiche, Radiologia e Sanità Pubblica (R.G.), Università degli Studi di Brescia, Italia.

Alessandro Pezzini (A)

Dipartimento di Scienze Cliniche e Sperimentali, Clinica Neurologica (D.P., M.L., V.M., S. Bonacina, A. Padovani, A. Pezzini), Università degli Studi di Brescia, Italia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH